Agustin Melian Forma Therapeutics Holdings, Inc. (FMTX) insider trading activity

FMTX Quotes by TradingView

Agustin Melian is EVP, Research & Development of Forma Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of FMTX, which is worth approximately $0. The most recent transaction as insider was on Oct 14, 2022, when has been sold 79,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Agustin Melian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 14 2022
SELL
Disposition due to a tender of shares in a change of control transaction
-
79,000 Reduced 100.0%
0 Common Stock
Jul 11 2022
BUY
Grant, award, or other acquisition
-
79,000 Added 50.0%
79,000 Common Stock

Also insider at

ALVR
Allovir, Inc. Healthcare
Chief Medical Officer
AM

Agustin Melian

EVP, Research & Development
Watertown, MA

Track Institutional and Insider Activities on FMTX

Follow Forma Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FMTX shares.

Notify only if

Insider Trading

Get notified when an Forma Therapeutics Holdings, Inc. insider buys or sells FMTX shares.

Notify only if

News

Receive news related to Forma Therapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FMTX